^That's the happy spin. I remember two years ago that there was a deal by this date, then that date... always looking promising, but no successful execution.
I'm disappointed. Ultimately, this company creates peptide products for pharmaceutical companies and sells the IP. If it's not successfully closing sales, then it's research work is worth nothing - hence the drift downward.
Very frustrated that the FPOs dropped way past the options, and have lost so much value over the past two or three years.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $839.8M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.42 | $3.475M | 2.414M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55564 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 6099 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |